Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Gynecologic Oncology Reports|February 13, 2025
N-acetylcysteine (NAC) supplementation improves dyspnea and may normalize von Willebrand plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVIDStefania Bellone, Eric R Siegel, Alessandro D Santin
Gynecologic Oncology Reports|November 29, 2023
Increased serum 1,25-dihydroxyvitamin D levels in gynecologic cancer patients with Post-Acute-Covid-Sequela (PASC)/Long COVIDStefania Bellone, Eric E Siegel, Alessandro D Santin
Expert Review of Anticancer Therapy|October 20, 2007
Advances in dendritic-cell-based therapeutic vaccines for cervical cancerStefania Bellone, Sergio Pecorelli, Martin J Cannon, et al.
Gynecologic Oncology Reports|December 27, 2016
Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)Alessandro D Santin, Stefania Bellone, Natalia Buza, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 2008
A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cellsXuelian Wang, Alessandro D Santin, Stefania Bellone, et al.
Gynecologic Oncology Reports|June 16, 2015
Improved survival of patients with hypermutation in uterine serous carcinomaAlessandro D Santin, Stefania Bellone, Floriana Centritto, et al.
Gynecologic Oncology Reports|October 22, 2024
Utility of next generation sequencing to unequivocally establish clonality in synchronous vs metastatic endometrial and ovarian carcinomasMichelle Greenman, Stefania Bellone, Tobias Hartwich, et al.
Gynecologic Oncology Reports|January 26, 2024
Increased von Willebrand and Factor VIII plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVIDStefania Bellone, Eric R Siegel, David E Scheim, et al.
Gynecologic Oncology Reports|June 28, 2018
Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatmentChanhee Han, Stefania Bellone, Luca Zammataro, et al.
Gynecologic Oncology Reports|August 7, 2024
Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancerMichelle Greenman, Stefania Bellone, Cem Demirkiran, et al.
Pageof 17